Aims This study aimed to examine if the cardiac changes associated with uraemic
cardiomyopathy are reversed by renal transplantation. Methods and results MEDLINE …

Uremic cardiomyopathy (UC), the peculiar cardiac remodeling secondary to the systemic
effects of renal dysfunction, is characterized by left ventricular (LV) diffuse fibrosis with …

Background Chronic kidney disease leads to cardiac remodelling of multifactorial origin
known as “uraemic cardiomyopathy”, the reversibility of which after kidney transplantation …

Background Cardiovascular disease is a significant cause of morbidity and mortality in
patients with end-stage renal disease (ESRD) and kidney transplant (KT) patients …

Background Growth differentiation factor 15 (GDF15) is markedly increased in end-stage
kidney disease and has been related to increased mortality in patients on dialysis. We …

Although kidney transplantation (KT) is the best treatment option for most patients with end-
stage kidney disease (ESKD) due to reduced mortality, morbidity and increased quality of …

Background The measurement of native T1 through cardiovascular magnetic resonance
(CMR) is a noninvasive method of assessing myocardial fibrosis without gadolinium …

Patients with chronic kidney disease (CKD) have an increased risk of premature mortality,
mainly due to cardiovascular causes. The association between hemodialysis and …

Background. Left ventricular hypertrophy (LVH) in patients with end stage renal disease
undergoing renal replacement is linked to an increased risk for cardiovascular diseases …

Background The assessment of left ventricular (LV) remodeling and its association with
mineral and bone disorder (MBD) in kidney transplant recipients (KTRs) have not been …